Metraipolis › archive › dc_be2a71ed4b63
A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for… — Europe PMC PMID:40855748
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40855748
- DOI
- 10.1002/jpn3.70200
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:00:35.469Z
- SHA-256 of the archived text
7c9431e241bea1b7c78c319f3bac6156f2f93f98ea95f98b35de697cf5c7b806- Stable URL of this page
https://metraipolis.com/documento/dc_be2a71ed4b63
How to cite
A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for… — Europe PMC PMID:40855748 — Europe PMC (en), https://europepmc.org/article/MED/40855748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be2a71ed4b63 (Metraipolis archive dc_be2a71ed4b63, sha256 7c9431e241bea1b7c78c319f3bac6156f2f93f98ea95f98b35de697cf5c7b806)
BibTeX
@misc{dcbe2a71ed4b63,
title = {A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for… — Europe PMC PMID:40855748},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40855748},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be2a71ed4b63; sha256 7c9431e241bea1b7c78c319f3bac6156f2f93f98ea95f98b35de697cf5c7b806},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40855748. Agents can read the archived copy with the MCP tool read_document.